Macular Degeneration

W. B. Thoreson, E. Margalit

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Macula r degeneration is a loss of central vision due to progressive degeneration of the macular region of the retina. It is estimated that 25% of those 75 years or older exhibit some age-related macular degeneration (ARMD). Juvenile forms, such as Stargardt's disease, can also strike younger individuals. ARMD can present as a wet (exudative) form involving choroidal neovascularization or a dry (nonexudative) form. Complement-related genes confer susceptibility suggesting that immune-mediated inflammatory responses contribute to ARMD. Oxidative damage to the retinal pigment epithelium may also contribute. Intravitreal injections of anti-vascular endothelial growth factor agents are the primary therapy for wet ARMD.

Original languageEnglish (US)
Title of host publicationReference Module in Biomedical Research
PublisherElsevier Inc.
ISBN (Print)9780128012383
DOIs
StatePublished - Dec 15 2014

Fingerprint

Macular Degeneration
Choroidal Neovascularization
Intravitreal Injections
Retinal Pigment Epithelium
Vascular Endothelial Growth Factor A
Retina
Genes

Keywords

  • Age-related macular degeneration (ARMD)
  • Choroidal neovascularization
  • Complement factor
  • Drusen
  • Fovea
  • Photoreceptors
  • Retina
  • Retinal degeneration
  • Retinal pigment epithelium (RPE)
  • Scotoma
  • Stargardt's disease
  • Vascular endothelial growth factor (VEGF)
  • Vision loss

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Thoreson, W. B., & Margalit, E. (2014). Macular Degeneration. In Reference Module in Biomedical Research Elsevier Inc.. https://doi.org/10.1016/B978-0-12-801238-3.05127-8

Macular Degeneration. / Thoreson, W. B.; Margalit, E.

Reference Module in Biomedical Research. Elsevier Inc., 2014.

Research output: Chapter in Book/Report/Conference proceedingChapter

Thoreson, WB & Margalit, E 2014, Macular Degeneration. in Reference Module in Biomedical Research. Elsevier Inc. https://doi.org/10.1016/B978-0-12-801238-3.05127-8
Thoreson WB, Margalit E. Macular Degeneration. In Reference Module in Biomedical Research. Elsevier Inc. 2014 https://doi.org/10.1016/B978-0-12-801238-3.05127-8
Thoreson, W. B. ; Margalit, E. / Macular Degeneration. Reference Module in Biomedical Research. Elsevier Inc., 2014.
@inbook{e7a54e9f21644e3ebc18dd9375014d3a,
title = "Macular Degeneration",
abstract = "Macula r degeneration is a loss of central vision due to progressive degeneration of the macular region of the retina. It is estimated that 25{\%} of those 75 years or older exhibit some age-related macular degeneration (ARMD). Juvenile forms, such as Stargardt's disease, can also strike younger individuals. ARMD can present as a wet (exudative) form involving choroidal neovascularization or a dry (nonexudative) form. Complement-related genes confer susceptibility suggesting that immune-mediated inflammatory responses contribute to ARMD. Oxidative damage to the retinal pigment epithelium may also contribute. Intravitreal injections of anti-vascular endothelial growth factor agents are the primary therapy for wet ARMD.",
keywords = "Age-related macular degeneration (ARMD), Choroidal neovascularization, Complement factor, Drusen, Fovea, Photoreceptors, Retina, Retinal degeneration, Retinal pigment epithelium (RPE), Scotoma, Stargardt's disease, Vascular endothelial growth factor (VEGF), Vision loss",
author = "Thoreson, {W. B.} and E. Margalit",
year = "2014",
month = "12",
day = "15",
doi = "10.1016/B978-0-12-801238-3.05127-8",
language = "English (US)",
isbn = "9780128012383",
booktitle = "Reference Module in Biomedical Research",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Macular Degeneration

AU - Thoreson, W. B.

AU - Margalit, E.

PY - 2014/12/15

Y1 - 2014/12/15

N2 - Macula r degeneration is a loss of central vision due to progressive degeneration of the macular region of the retina. It is estimated that 25% of those 75 years or older exhibit some age-related macular degeneration (ARMD). Juvenile forms, such as Stargardt's disease, can also strike younger individuals. ARMD can present as a wet (exudative) form involving choroidal neovascularization or a dry (nonexudative) form. Complement-related genes confer susceptibility suggesting that immune-mediated inflammatory responses contribute to ARMD. Oxidative damage to the retinal pigment epithelium may also contribute. Intravitreal injections of anti-vascular endothelial growth factor agents are the primary therapy for wet ARMD.

AB - Macula r degeneration is a loss of central vision due to progressive degeneration of the macular region of the retina. It is estimated that 25% of those 75 years or older exhibit some age-related macular degeneration (ARMD). Juvenile forms, such as Stargardt's disease, can also strike younger individuals. ARMD can present as a wet (exudative) form involving choroidal neovascularization or a dry (nonexudative) form. Complement-related genes confer susceptibility suggesting that immune-mediated inflammatory responses contribute to ARMD. Oxidative damage to the retinal pigment epithelium may also contribute. Intravitreal injections of anti-vascular endothelial growth factor agents are the primary therapy for wet ARMD.

KW - Age-related macular degeneration (ARMD)

KW - Choroidal neovascularization

KW - Complement factor

KW - Drusen

KW - Fovea

KW - Photoreceptors

KW - Retina

KW - Retinal degeneration

KW - Retinal pigment epithelium (RPE)

KW - Scotoma

KW - Stargardt's disease

KW - Vascular endothelial growth factor (VEGF)

KW - Vision loss

UR - http://www.scopus.com/inward/record.url?scp=84945417823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945417823&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-801238-3.05127-8

DO - 10.1016/B978-0-12-801238-3.05127-8

M3 - Chapter

SN - 9780128012383

BT - Reference Module in Biomedical Research

PB - Elsevier Inc.

ER -